Senomyx Inc. (NASDAQ:SNMX) shares were up 4.1% during trading on Tuesday . The company traded as high as $2.54 and last traded at $2.52, with a volume of 122,395 shares trading hands. The stock had previously closed at $2.42.

Separately, Zacks Investment Research cut shares of Senomyx from a “hold” rating to a “sell” rating in a research report on Tuesday, April 5th.

The stock’s market cap is $112.80 million. The stock has a 50-day moving average of $2.84 and a 200 day moving average of $2.83.

Senomyx (NASDAQ:SNMX) last announced its quarterly earnings data on Thursday, April 28th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.03. The company had revenue of $6.30 million for the quarter, compared to the consensus estimate of $5.78 million. The company’s revenue was up 26.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.11) earnings per share. On average, equities analysts forecast that Senomyx Inc. will post ($0.25) EPS for the current fiscal year.

An institutional investor recently raised its position in Senomyx stock. Turner Investments L.P. raised its position in Senomyx Inc. (NASDAQ:SNMX) by 10.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 345,000 shares of the company’s stock after buying an additional 33,000 shares during the period. Turner Investments L.P. owned about 0.78% of Senomyx worth $1,301,000 as of its most recent filing with the SEC.

Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.